Devices/Recall·openFDA/device

Stryker Sustainability Solutions — Class II: BARD Dynamic Deca Steerable, Product Number 201101; REPROCESSED ELECTROPHYSIOLOGY CATHETER

MediumPublished May 20, 2026· AI-analyzed May 25, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

Stryker Sustainability Solutions has initiated a Class II recall for BARD Dynamic Deca Steerable reprocessed electrophysiology catheters (Product Number 201101) due to reports of incomplete seals on the sterile packaging.

Who it affects

This recall affects Stryker Sustainability Solutions, healthcare facilities utilizing reprocessed electrophysiology catheters, and hospital departments involved in sterile processing and cardiac electrophysiology.

Why it matters

An incomplete seal compromises the sterile barrier of a medical device, which may lead to healthcare-associated infections or procedural delays. For firms specializing in device reprocessing, this suggests a potential failure in the final packaging or seal validation phases of the manufacturing process. Regulatory professionals should note this as a critical quality control point for maintaining device integrity throughout the distribution chain.

Practical takeaway

QA and Sterility Assurance teams should review validation protocols for pouch/tray sealing processes, especially for reprocessed single-use devices. Facilities utilizing these specific reprocessed catheters should immediately verify inventory against the affected product number and follow manufacturer instructions for quarantine or return.

FDA source material

Class II. Reason: Incomplete seals on sterile product. Product: BARD Dynamic Deca Steerable, Product Number 201101; REPROCESSED ELECTROPHYSIOLOGY CATHETER. Firm: Stryker Sustainability Solutions (Tempe AZ United States). Status: Ongoing.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.